Even with the only approved CAS9 based treatment out there, CRISPR is still years away from ... I’d have to assume at today’s prices, it would cost at least $150 million or so to make this ...

CRISPR technology has revolutionized genetic testing and disease detection, offering precise, rapid, and cost-effective diagnostic ... rapid detection and treatment. 18 CRISPR-based diagnostics ...

Around 1,700 people could be eligible for the one-time treatment, which is seen as a less risky alternative to a donor stem ...

People in England with sickle cell will be able to get the world’s first CRISPR-based medicine under an agreement between the ...

A GROUNDBREAKING genetic treatment with the potential to cure sickle cell disease will be rolled out on the NHS. The one-off ...

The gene-editing treatment will be available to certain patients with sickle cell disease in England as Vertex commits to collecting additional data.

Vertex and CRISPR say they plan to provide it through a network of independently operated, authorised treatment centres ... in 2022 and launched at a one-off cost of $2.8 million.

Charity organisation Sickle Cell Society has described the recommendation as a “major breakthrough” for sickle cell patients.

One sickle cell patient told ITV News the new gene therapy being rolled out for use on the NHS means they "finally have something to look towards". | ITV National News ...

Advances in CRISPR technologies promise to accelerate the burgeoning pipeline of gene-editing therapies and broaden access to these disease-altering therapies.